chartexchange

KPTI
Karyopharm Therapeutics Inc.
stockNASDAQ

At CloseOct 22, 2026 3:59:46 PM EDT
0.55USD+28.723%(+0.12)7,404,384
Pre-marketOct 22, 2026 9:18:30 AM EDT
0.42USD-1.037%(-0.00)
After-hoursOct 22, 2026 4:59:30 PM EDT
0.561USD+2.691%(+0.015)
0.5300Bid0.5400Ask0.0100Spread
Loading…
Loading…
Healthcare
Biotechnology
CEO
Michael Kauffman
HQ
Newton, MA, USA
Previous Close
$0.42
Beta
0.61
52-Week High
$10.99 2026-02-24
52-Week Low
$0.31 2026-10-15
SMA 50
$1.41
SMA 200
$6.29
Avg. Vol 10D
1.43M
Avg. Vol 30D
1.57M
Avg. Vol 90D
1.47M
Relative Vol
4.45
14.82M
8.5200%
1,939
Nov 2, 2026 (11d)
Feb 26, 2025 · 1-for-15 (reverse)
KPTI Profile

karyopharm therapeutics inc. is a clinical-stage pharmaceutical company focused on discovery and development of novel first-in-class drugs directed against nuclear transport targets for the treatment of cancer and other major diseases. for more information, please visit www.karyopharm.com

KPTI Performance
PeriodPriceDateChangeBeta
1W0.352026-10-15+55.30%-4.086
1M1.822026-09-22-70.07%1.642
3M7.182026-07-22-92.41%0.174
6M9.552026-04-22-94.30%0.121
1Y6.142025-10-22-91.13%0.610
2Y12.762024-10-22-95.73%—
5Y79.052021-10-22-99.31%1.240
KPTI Stock Summary

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) stock price today is $0.54, and today's volume is 6,984,901. KPTI is up 28.369% today. The 30 day average volume is 1.57M. KPTI market cap is $12.36M with 22.68M shares outstanding.